Get started
HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG)HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG)HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG)

HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

HEMO chart


Full chart

Key stats


Market capitalization
‪12.56 M‬ GBP
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.7 GBP
Net income (FY)
‪−6.69 M‬ GBP
Revenue (FY)
0.00 GBP
Shares float
‪3.20 M‬
Beta (1Y)
0.93

Employees


Employees (FY)
22
Change (1Y)
0
Revenue / Employee (1Y)
0.00 GBP
Net income / Employee (1Y)
‪−304.12 K‬ GBP

About HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG)


Sector
Health Technology
Industry
Biotechnology
CEO
Vladislav Sandler
Website
hemogenyx.com
Headquarters
London
Founded
2013
ISIN
GB00BQVXM815
FIGI
BBG00BDKH4D5
HemoGenyx Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of a suite of products to address current problems associated with the treatment of blood disorders such as cancers and autoimmune diseases, with bone marrow, or hematopoietic stem cell, transplants, and with viral infections. It operates through the United Kingdom and United States geographical segments. The company was founded by Alexis M. Sandler and Vladislav Sandler in 2012 and is headquartered in London, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

HEMO news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HEMO is 370.0 GBX — it has increased by 3.21% in the past 24 hours. Watch HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) stocks are traded under the ticker HEMO.
HEMO stock has fallen by −2.63% compared to the previous week, the month change is a −46.35% fall, over the last year HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) has showed a −53.75% decrease.
HEMO reached its all-time high on Aug 26, 2020 with the price of 6,155.0 GBX, and its all-time low was 270.0 GBX and was reached on Dec 17, 2024. View more price dynamics on HEMO chart.
See other stocks reaching their highest and lowest prices.
HEMO stock is 4.29% volatile and has beta coefficient of 0.93. Track HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) stock price on the chart and check out the list of the most volatile stocks — is HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) there?
Today HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) has the market capitalization of ‪12.97 M‬, it has increased by 2.43% over the last week.
Yes, you can track HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) financials in yearly and quarterly reports right on TradingView.
HEMO net income for the last half-year is ‪−2.81 M‬ GBP, while the previous report showed ‪−2.37 M‬ GBP of net income which accounts for −18.71% change. Track more HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) financial stats to get the full picture.
No, HEMO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 22.00 employees. See our rating of the largest employees — is HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) on this list?
Like other stocks, HEMO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) stock shows the strong sell signal. See more of HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.